Renal Safety of Antiviral Medications

Introduction to Antiviral Medications

Valacyclovir is considered safer for the kidneys than acyclovir due to its less frequent dosing and similar renal safety profile when properly dosed according to renal function, as recommended by the Infectious Diseases Society of America 1, 2

For patients with renal impairment, dose adjustments are necessary, with recommended doses as follows:
CrCl (mL/min) Recommended Dose
30-49 500 mg-1 g every 12 hours
10-29 500 mg-1 g every 24 hours
<10 500 mg every 24 hours
Patients with pre-existing renal dysfunction require dose adjustment since acyclovir is primarily excreted via the kidneys through glomerular filtration and tubular secretion 3

Inadequate hydration can increase the risk of nephropathy, and patients should maintain adequate fluid intake of at least 1.5L daily, as recommended by the European Society for Medical Oncology 4
Maintaining adequate hydration is crucial to reduce the risk of nephropathy 3
Monitor renal function at initiation of treatment and once or twice weekly during treatment, as recommended by the Centers for Disease Control and Prevention 5

High-dose valacyclovir (8g/day) has been associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in immunocompromised patients, with a strength of evidence rated as high by the Centers for Disease Control and Prevention 5
Acyclovir can cause renal impairment through crystalluria and obstructive nephropathy, affecting up to 20% of patients 3, 6
Patients with renal impairment are at increased risk for acyclovir-induced neurotoxicity, although the exact strength of evidence is not provided 3, 6

For patients with severe renal impairment, valacyclovir and acyclovir should be used with caution, with proper dose adjustment, regular monitoring of renal function, and maintenance of adequate hydration, as recommended by the American College of Physicians 1, 2
The American Academy of Neurology and other guideline societies recommend careful monitoring of patients with renal dysfunction, as acyclovir can accumulate and lead to serious adverse effects 3, 6
The treatment duration for HSV encephalitis should be 14-21 days, with consideration of repeat CSF testing to confirm viral clearance, according to the Infectious Diseases Society of America 3, 6